Future studies will further clarify this relationship between CD4+ FoxP3+ Tregs and cytotoxic CD8 T cells in the HNSCC tumor microenvironment following BRB-E administration. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.